Cargando…
Effect of antitumor treatments on triple-negative breast cancer patients: A PRISMA-compliant network meta-analysis of randomized controlled trials
BACKGROUND: Triple-negative breast cancer (TNBC) lacks the expression of the estrogen receptor, progesterone receptor, and receptor tyrosine-protein kinase erbB-2 (HER2/neu), which renders hormone-related endocrine and targeted therapy essentially futile. OBJECTIVE: We performed a meta-analysis to a...
Autores principales: | Tian, Qiuhong, Du, Peng, Li, Sen, Bai, Zhenzhu, Yang, Yong, Zeng, Jinsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690714/ https://www.ncbi.nlm.nih.gov/pubmed/29137021 http://dx.doi.org/10.1097/MD.0000000000008389 |
Ejemplares similares
-
Prevalence of placenta previa among deliveries in Mainland China: A PRISMA-compliant systematic review and meta-analysis
por: Fan, Dazhi, et al.
Publicado: (2016) -
Diagnostic value of neutrophil-lymphocyte ratio in preeclampsia: A PRISMA-compliant systematic review and meta-analysis
por: Zheng, Wen-Fei, et al.
Publicado: (2019) -
Association between polycystic ovary syndrome and the risk of pregnancy complications: A PRISMA-compliant systematic review and meta-analysis
por: Yu, Hai-Feng, et al.
Publicado: (2016) -
Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study)
por: Kong, Xiang, et al.
Publicado: (2016) -
Endometriosis-associated malignant transformation in abdominal surgical scar: A PRISMA-compliant systematic review
por: Mihailovici, Anca, et al.
Publicado: (2017)